Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

The simple term “stem cell” actually refers to many different types of cells. The tissue-specific stem cells, or adult stem cells, replenish tissues throughout our lives. Embryonic stem cells exist ...

The last thing Maria Torres expected was to be diagnosed with type 2 diabetes. She exercised, ate well and kept her weight under control. There had to be some mistake. Maria asked her doctor to repeat ...

CIRM is governed by 35 dedicated Californians representing patients, researchers and the biotechnology industry whose knowledge, passion and commitment to CIRM’s mission has guided the organization ...

一种由抑制性神经元组成的细胞治疗产品，可以在脑外伤后迁移、整合和恢复神经功能。 近 6 万美国人（包括 700,000 万加州人）因脑外伤而患有永久性的身体或心理健康问题，但目前尚无治疗方法。我们建议研究创造一种能够恢复这些患者神经功能的细胞治疗 ...

If you would like to contact CIRM regarding questions you may have about employment opportunities, please contact us at [email protected]. CIRM encourages job seekers to apply for specific job openings ...

San Francisco, CA – California’s stem cell agency, the California Institute for Regenerative Medicine (CIRM) today approved $150 million in new funding to help move promising stem cell-based therapies ...

CIRM publishes Form 700s for all board members and executive staff on a yearly basis.

CIRM has one singular mission: Accelerating world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world. A dedication to ...

One of the most complex aspects of autism is that it is not one disease—but many. Known more accurately as the autism spectrum disorder, or ASD, experts have long been trying to tease apart the ...

Currently, CIRM is not accepting new applications for any existing Clinical (CLIN), Translational (TRAN), Education (EDUC), or Infrastructure (INFR) opportunities. However, CIRM will accept ...

Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem ...